Skip to content

GAV 2.0 FX272TRecalls & reported problems

Aesculap AG · GAV 2.0 SYST WITH SPRUNG RES.5/30 · Class 2 · Implant

Data updated Oct 13, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 04041906500801), received between Oct 23, 2020 and Oct 23, 2020 — classified as 1 injury.

The most frequently reported specific device problem is “Infusion or Flow Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Infusion or Flow Problem1

Patient problems

  • Hydrocephalus1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryOct 23, 2020Infusion or Flow Problem; Infusion or Flow Problem

    IT AS REPORTED THAT THERE WAS AN BLOCKAGE/UNDER-DRAINAGE PROBLEM WITH A GAV 2.0 VALVE. PATIENT INFORMATION: AGE: (B)(6) YEARS. WEIGHT: (B)(6) KG. HEIGHT: 164 CM. GENDER: UNKNOWN. DATE OF IMPLANTATION: (B)(6) 2020. DATE OF REMOVAL: (B)(6) 2020.

    Patient problems: Hydrocephalus

    MAUDE report 10726266 ↗

Other Shunt, central nervous system and components devices

All Shunt, central nervous system and components devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page